{
    "organizations": [],
    "uuid": "9993450fadf5914f856adc4b2e018ec8cd17b088",
    "author": "",
    "url": "https://www.reuters.com/article/brief-seattle-genetics-to-acquire-cascad/brief-seattle-genetics-to-acquire-cascadian-therapeutics-idUSASB0C36G",
    "ord_in_thread": 0,
    "title": "BRIEF-Seattle Genetics To Acquire Cascadian Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 34 AM / in 9 minutes BRIEF-Seattle Genetics To Acquire Cascadian Therapeutics Reuters Staff \nJan 31 (Reuters) - Seattle Genetics Inc: \n* SEATTLE GENETICS TO ACQUIRE CASCADIAN THERAPEUTICS, ADDING LATE-STAGE BREAST CANCER PROGRAM TO ITS ONCOLOGY PIPELINE \n* SEATTLE GENETICS TO ACQUIRE CASCADIAN THERAPEUTICS, ADDING LATE-STAGE BREAST CANCER PROGRAM TO ITS ONCOLOGY PIPELINE \n* DEAL FOR $10.00 PER SHARE IN CASH, OR APPROXIMATELY $614 MILLION. \n* TRANSACTION WAS UNANIMOUSLY APPROVED BY BOARDS OF DIRECTORS OF BOTH COMPANIES \n* SEES REVENUE OF $128 MILLION TO $130 MILLION FOR THREE MONTHS ENDED DEC. 31 \n* SEATTLE GENETICS- UNDER TERMS OF DEAL, CO WILL COMMENCE TENDER OFFER ON/ABT FEB 8 TO BUY ALL OF OUTSTANDING SHARES OF STOCK OF CASCADIAN THERAPEUTICS \n* SEATTLE GENETICS - ‍IN CONNECTION WITH TRANSACTION, CO HAS SECURED FINANCING COMMITMENT OF $400 MILLION FROM BARCLAYS & JPMORGAN-CHASE BANK​ \n* Q4 REVENUE VIEW $114.2 MILLION -- THOMSON REUTERS I/B/E/S \n* AS OF DECEMBER 31, 2017, SEATTLE GENETICS HAD APPROXIMATELY $413 MILLION IN CASH AND CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS Source text for Eikon: Further company coverage:",
    "published": "2018-01-31T13:34:00.000+02:00",
    "crawled": "2018-01-31T13:55:44.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "minute",
        "genetics",
        "acquire",
        "cascadian",
        "therapeutic",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "seattle",
        "genetics",
        "inc",
        "seattle",
        "genetics",
        "acquire",
        "cascadian",
        "therapeutic",
        "adding",
        "breast",
        "cancer",
        "program",
        "oncology",
        "pipeline",
        "seattle",
        "genetics",
        "acquire",
        "cascadian",
        "therapeutic",
        "adding",
        "breast",
        "cancer",
        "program",
        "oncology",
        "pipeline",
        "deal",
        "per",
        "share",
        "cash",
        "approximately",
        "million",
        "transaction",
        "unanimously",
        "approved",
        "board",
        "director",
        "company",
        "see",
        "revenue",
        "million",
        "million",
        "three",
        "month",
        "ended",
        "seattle",
        "term",
        "deal",
        "co",
        "commence",
        "tender",
        "offer",
        "feb",
        "buy",
        "outstanding",
        "share",
        "stock",
        "cascadian",
        "therapeutic",
        "seattle",
        "genetics",
        "connection",
        "transaction",
        "co",
        "secured",
        "financing",
        "commitment",
        "million",
        "barclays",
        "q4",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "december",
        "seattle",
        "genetics",
        "approximately",
        "million",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}